Northrop Grumman (NOC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 sales rose 7% year-over-year to $10.2 billion, with growth across all four segments, led by Aeronautics Systems at 14%.
Net earnings for Q2 2024 increased 16% to $940 million, and diluted EPS rose 19% to $6.36, driven by higher operating income and a lower share count.
Operating income grew 13% to $1.09 billion, reflecting cost efficiencies and improved performance.
Free cash flow surged 80% to $1.1 billion, supported by improved working capital and lower tax payments.
Backlog reached $83.1 billion, with net awards of $15.1 billion and a book-to-bill ratio of 1.5x.
Financial highlights
Q2 2024 sales: $10.2B (+7% YoY); net earnings: $940M (+16% YoY); operating income: $1.09B (+13% YoY).
Diluted EPS: $6.36 (+19% YoY); operating margin rate: 10.7% (up 60 bps YoY).
Free cash flow: $1.1B (+80% YoY); operating cash flow: $1.4B.
Quarterly dividend increased by 10% in May 2024, marking 21 consecutive annual increases.
Cash and cash equivalents totaled $3.3 billion at quarter-end.
Outlook and guidance
2024 sales guidance raised to $41.0–$41.4 billion; MTM-adjusted EPS guidance increased to $24.90–$25.30.
Free cash flow guidance maintained at $2.25B–$2.65B; confident in >15% three-year free cash flow CAGR.
Segment guidance updated to reflect realignment of Strategic Deterrent Systems from Space to Defense Systems.
Guidance reflects expectations amid inflation, labor, supply chain, and geopolitical risks; does not assume government shutdown or spending cuts.
Margins expected to improve in 2025 and beyond as macro headwinds dissipate and business mix shifts to more profitable programs.
Latest events from Northrop Grumman
- Backlog and sales growth accelerate as major defense and space programs drive future revenue.NOC
Bernstein 42nd Annual Strategic Decisions Conference28 May 2026 - Board elections and management proposals passed; Independent Chair proposal rejected.NOC
AGM 202620 May 2026 - Shareholders are urged to vote all shares by May 17 ahead of the May 20, 2026 annual meeting.NOC
Proxy filing13 May 2026 - Q1 2026 delivered 4% sales growth, 85% EPS rise, robust backlog, and reaffirmed 2026 guidance.NOC
Q1 202621 Apr 2026 - Record backlog and double-digit Q4 growth set the stage for accelerating expansion in 2026.NOC
Q4 202512 Apr 2026 - Shareholders will vote on director elections, executive pay, auditor ratification, and a board chair proposal.NOC
Proxy filing3 Apr 2026 - Accelerating defense demand fuels growth, investment, and innovation across all business segments.NOC
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Board re-elected, dividends raised, and shareholder clawback proposal rejected.NOC
AGM 20253 Feb 2026 - Growth, margin expansion, and international demand drive a resilient, diversified portfolio.NOC
Morgan Stanley‘s 12th Annual Laguna Conference 202420 Jan 2026